Effect of Denosumab on circulating microRNAs after 2 years of treatment in postmenopausal women
David Carro-Vazquez

David Carro-Vazquez
TAmiRNA GmbH, Austria.
© 2021 – International Federation of Musculoskeletal Research Societies